Calumet, Inc. (CLMT) stock forecast and price target
Price $34.30 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($34.30)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.74 | +242.9% | $5.3B |
| Next fiscal year ends December 31, 2027 | $3.17 | — | $5.0B |
| Next quarter ends December 31, 2026 | $0.82 | — | $1.1B |
| Quarter after ends March 31, 2027 | $0.95 | — | $1.3B |
Consensus of the analysts covering Calumet, updated daily. In the last 30 days 2 estimates were raised and 1 lowered.
Our model vs. Wall Street
Analysts see 62.7% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Calumet’s intrinsic value about 62% below today’s market value, and it scores 0.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Calumet stock price target?
The average 12-month target from 5 analysts is $55.80, 62.7% above the current price of $34.30 Targets range from $40.00 to $75.00.
Is Calumet a buy according to analysts?
The consensus rating is “Buy” (2 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Calumet expected to earn?
Analysts expect EPS of $-0.74 for the fiscal year ending December 31, 2026 and $3.17 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.